4.6 Article

The long noncoding RNA HOXA11-AS promotes lung adenocarcinoma proliferation and glycolysis via the microRNA-148b-3p/PKM2 axis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

The long noncoding RNA glycoLINC assembles a lower glycolytic metabolon to promote glycolysis

Youming Zhu et al.

Summary: This study reveals a novel long noncoding RNA (lncRNA) called gLINC that acts as a backbone for the formation of a metabolon involving glycolytic enzymes and lactate dehydrogenase A. The gLINC metabolon enhances glycolytic flux, ATP production, and cell survival under serine deprivation. Overexpression of gLINC in cancer cells promotes xenograft growth in mice on a serine-deprived diet, suggesting its role in cancer cell adaptation.

MOLECULAR CELL (2022)

Article Oncology

Long noncoding RNA LINC00930 promotes PFKFB3-mediated tumor glycolysis and cell proliferation in nasopharyngeal carcinoma

Baoyu He et al.

Summary: In this study, a metabolism-related lncRNA, LINC00930, was identified and found to be upregulated and associated with tumorigenesis, metastasis, and poor prognosis in nasopharyngeal carcinoma (NPC). Functionally, LINC00930 promoted glycolysis activity and cell proliferation. Mechanistically, LINC00930 regulated the expression of PFKFB3 through epigenetic modifications. Clinically, targeting LINC00930 and PFKFB3 in combination with radiotherapy induced tumor regression.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Article Gastroenterology & Hepatology

F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer

Jie Hong et al.

Summary: The study revealed a positive correlation between Fusobacterium nucleatum and high glucose metabolism in patients with colorectal cancer (CRC), suggesting a potential role of gut microbiota in CRC development. Mechanistically, Fusobacterium nucleatum activated the lncRNA ENO1-IT1 pathway to regulate CRC cell glucose metabolism and biological functions. Targeting the ENO1 pathway may have therapeutic implications for CRC patients with elevated Fusobacterium nucleatum levels.
Review Biochemistry & Molecular Biology

The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs

Dexter L. Puckett et al.

Summary: PKM2 plays a significant role in cancer cell metabolism, proliferation, and migration through its inactive dimeric form, while also being essential for cellular homeostasis in non-cancer tissues. Research targeting various tissues beyond cancer, such as the kidney, liver, adipose, and pancreas, contributes to a better understanding of PKM2's functions in different diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Cell Biology

Gene regulation by long non-coding RNAs and its biological functions

Luisa Statello et al.

Summary: Recent studies have shed new light on the biogenesis and functions of long non-coding RNAs (lncRNAs), showcasing their diverse roles in gene regulation and signaling pathways, particularly in the contexts of neuronal disorders, immune responses, and cancer. The discovery of unique biogenesis pathways and subcellular localizations of lncRNAs has opened up potential therapeutic avenues for targeting lncRNAs in various biological and pathophysiological conditions.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)

Review Oncology

Involvement of Long Non-Coding RNAs in Glucose Metabolism in Cancer

Amar Balihodzic et al.

Summary: Long non-coding RNAs (lncRNAs) are a diverse group of transcripts that regulate various cellular functions and are involved in cancer-related metabolic abnormalities. By modulating gene expression and signaling pathways, they enhance glucose uptake in cancer cells, promoting cancer progression.

CANCERS (2021)

Article Oncology

Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics

Susi Zhu et al.

Summary: PKM2 plays a crucial role in tumor metabolism and its dysregulation is associated with cancer development and progression. Researchers are investigating the function and therapeutic potential of PKM2 in cancer, particularly its interactions with lncRNAs. The role of PKM2 in the tumor microenvironment (TME) is also being studied for its implications in cancer therapy.

CANCER LETTERS (2021)

Article Oncology

Long non-coding RNA NORAD promotes the prostate cancer cell extracellular vesicle release via microRNA-541-3p-regulated PKM2 to induce bone metastasis of prostate cancer

Chuan-yi Hu et al.

Summary: This study found that NORAD is highly expressed in PCa tissues and cell lines, and NORAD knockdown can reduce EVs secretion and internalization, inhibit proliferation, migration, and bone metastasis of PCa cells. Additionally, NORAD interacts with miR-541-3p, leading to upregulation of PKM2, which further promotes the transfer of PKH67-labeled EVs to bone marrow stromal cells.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Oncology

被撤回的出版物: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2 (Retracted article. See vol. 42, 2023)

Guizhi Jia et al.

Summary: This study identified the upregulation of LNCAROD in HCC patients, predicting a poor prognosis, and revealed that LNCAROD promotes HCC progression through PKM2-mediated glycolysis enhancement. The molecular mechanism involves the interaction with different factors and sponging miR-145-5p to maintain PKM2 levels, especially under hypoxic conditions, providing a potential diagnostic marker and therapeutic target for HCC patients.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Review Oncology

The metabolism of cancer cells during metastasis

Gabriele Bergers et al.

Summary: This review discusses the metabolic rewiring in cancer cells during the metastatic cascade and the distinct metabolic features of primary tumors and metastases. Metastasis is the leading cause of death in most cancer patients, and targeting metastatic seeding and colonization remains a significant challenge. Adjusting metabolism may provide therapeutic opportunities to prevent or reduce metastasis, and targeting the new metabolic traits in established metastases could lead to their eradication.

NATURE REVIEWS CANCER (2021)

Article Oncology

Cancer treatment and survivorship statistics, 2019

Kimberly D. Miller et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Review Biochemistry & Molecular Biology

Pyruvate kinase M2: A simple molecule with complex functions

Mohammed Alquraishi et al.

FREE RADICAL BIOLOGY AND MEDICINE (2019)

Review Biochemistry & Molecular Biology

Noncoding RNA:RNA Regulatory Networks in Cancer

Jia Jia Chan et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Medicine, General & Internal

Lung cancer: current therapies and new targeted treatments

Fred R. Hirsch et al.

LANCET (2017)

Article Oncology

Cancer Statistics, 2017

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2017)

Article Biochemistry & Molecular Biology

PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation

Ninel Azoitei et al.

MOLECULAR CANCER (2016)

Review Pathology

MicroRNAs in Cancer

Gianpiero Di Leva et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)

Editorial Material Multidisciplinary Sciences

THE DOMINANT MALIGNANCY

Eric Bender

NATURE (2014)

Article Biochemistry & Molecular Biology

A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?

Leonardo Salmena et al.

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Review Multidisciplinary Sciences

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Matthew G. Vander Heiden et al.

SCIENCE (2009)